4.7 Article

In silico study identifies peptide inhibitors that negate the effect of non-synonymous mutations in major drug targets of SARS-CoV-2 variants

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

High-throughput virtual screening of drug databanks for potential inhibitors of SARS-CoV-2 spike glycoprotein

Ibrahim E. Awad et al.

Summary: COVID-19 has become a global pandemic, and finding effective treatments is urgently needed. This study applied computational methods to investigate FDA-approved drugs and found that silodosin has good binding ability to the viral RBD S-1 and has potential to interfere with the spike-ACE2 interactions.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)

Article Pharmacology & Pharmacy

Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern

Laura Vangeel et al.

Summary: Remdesivir and its parent nucleoside, molnupiravir and its parent nucleoside, and the viral protease inhibitor nirmatrelvir have equipotent antiviral activity against the ancestral SARS-CoV2 strain and the variants of concern including Omicron.

ANTIVIRAL RESEARCH (2022)

Review Virology

The emergence and epidemic characteristics of the highly mutated SARS-CoV-2 Omicron variant

Dandan Tian et al.

Summary: The Omicron variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in Botswana in November 2021 and has since become the dominant strain in many countries. With a high number of mutations, it presents new challenges for preventing and controlling COVID-19. This review aims to provide a scientific reference by analyzing and summarizing the biological characteristics, epidemic features, immune escape, and vaccine reactivity of the Omicron variant.

JOURNAL OF MEDICAL VIROLOGY (2022)

Article Multidisciplinary Sciences

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies

Yunlong Cao et al.

Summary: The Omicron variant of SARS-CoV-2 contains 15 mutations in the receptor-binding domain, leading to evasion of over 85% of tested neutralizing antibodies. Different epitope groups of neutralizing antibodies are affected to varying degrees by single mutations of Omicron. Antibodies targeting the conserved region of sarbecovirus remain most effective against Omicron.

NATURE (2022)

Article Multidisciplinary Sciences

Management of validation of HPLC method for determination of acetylsalicylic acid impurities in a new pharmaceutical product

Malgorzata Kowalska et al.

Summary: The study focuses on validating a method for determining the content of salicylic acid and unknown impurities in new pharmaceutical tablets. HPLC was used for separation, and the method was confirmed to be linear, precise, and accurate through validation tests.

SCIENTIFIC REPORTS (2022)

Article Cell Biology

Mutational landscape and in silico structure models of SARS-CoV-2 spike receptor binding domain reveal key molecular determinants for virus-host interaction

Shijulal Nelson-Sathi et al.

Summary: This study provides insights into the structural and molecular evolution of SARS-CoV-2 RBD mutants by analyzing global genomic data. The findings reveal changes in the binding interface between the virus and ACE2, but the stability and binding affinity are maintained. This research is important for understanding the evolution of virus-host binding interfaces.

BMC MOLECULAR AND CELL BIOLOGY (2022)

Article Chemistry, Medicinal

Main protease mutants of SARS-CoV-2 variants remain susceptible to nirmatrelvir

Sven Ullrich et al.

Summary: The COVID-19 pandemic continues to pose a threat to public health, with emerging variants of SARS-CoV-2 potentially impacting the effectiveness of available vaccines. However, research suggests that the specific M-pro inhibitor nirmatrelvir remains effective against these variants.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2022)

Article Biochemistry & Molecular Biology

SARS-COV-2 Mpro conformational changes induced by covalently bound ligands

Glaucio Monteiro Ferreira et al.

Summary: This study explored the interaction and conformational changes of SARS-CoV-2 main protease (M-pro) with ligands through molecular dynamics simulations. The results showed that the dimeric form of Mpro had stable interactions with ligands, while the monomeric form exhibited unrealistic flexibility. Additionally, the interactions with residues His41, Gly143, His163, Glu166, and Gln189 were postulated to significantly affect the inhibitory activity of the ligands.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)

Article Virology

Molecular evolutionary characteristics of SARS-CoV-2 emerging in the United States

Shihang Wang et al.

Summary: Through bioinformatics analysis of SARS-CoV-2 in the United States, this study revealed the nucleotide mutation rate, evolution rate, and mutation site characteristics of the S protein, providing insights for future surveillance and prevention of virus variants.

JOURNAL OF MEDICAL VIROLOGY (2022)

Review Biochemistry & Molecular Biology

The spike glycoprotein of SARS-CoV-2: A review of how mutations of spike glycoproteins have driven the emergence of variants with high transmissibility and immune escape

Pedro F. N. Souza et al.

Summary: This article discusses the mutations of SARS-CoV-2 and how these mutations have led to the emergence of new variants that are more transmissible and aggressive. The crucial role of the S protein in SARS-CoV-2 infection and evolution is explored, along with the impact of mutations on its functions.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2022)

Review Biochemistry & Molecular Biology

Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants

Cong Sun et al.

Summary: The persistent COVID-19 pandemic has had a significant impact on global society since 2020, resulting in a huge burden on public health. The emergence of various SARS-CoV-2 variants with critical mutations has affected the molecular characteristics of viral proteins and exhibited different behaviors in terms of immune evasion, transmissibility, and clinical manifestations during infection. Several of these variants, known as Variants of Concern (VOC) according to the World Health Organization, have posed challenges to COVID-19 control efforts due to their rapid global spread and enhanced immune evasion from current antibodies and vaccines. The recent Omicron variant has further intensified global anxiety in the ongoing pandemic. Therefore, it is crucial to comprehensively investigate the mutational patterns, impact on viral dynamics, and influence on populational immunity in order to facilitate drug and vaccine development and inform global public health policymaking.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Article Biochemistry & Molecular Biology

Identification of natural inhibitors against Mpro of SARS-CoV-2 by molecular docking, molecular dynamics simulation, and MM/PBSA methods

Priyanka Sharma et al.

Summary: The recent outbreak of the COVID-19 pandemic has highlighted the urgent need for drug discovery against SARS-CoV-2. In this study, a structure-based virtual screening approach and molecular dynamics simulation were used to identify potential inhibitors of the main protease (Mpro) of SARS-CoV-2. Several phytochemicals were identified as potential drug candidates, and further analysis showed that three compounds form stable complexes with Mpro and could be used as potential inhibitors of SARS-CoV-2 Mpro. Further investigation is needed to validate their effectiveness in clinical trials.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)

Article Immunology

Recent advances in SARS-CoV-2 Spike protein and RBD mutations comparison between new variants Alpha (B.1.1.7, United Kingdom), Beta (B.1.351, South Africa), Gamma (P.1, Brazil) and Delta (B.1.617.2, India)

Paulo R. S. Sanches et al.

Summary: New variants of SARS-CoV-2 Alpha, Beta, Gamma, and Delta have rapidly spread in various countries, and mutations in the RBD spike protein may lead to increased infectivity compared to the Wuhan 2019 strain.

JOURNAL OF VIRUS ERADICATION (2021)

Article Medicine, General & Internal

Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19

Shruti Gupta et al.

Summary: A multicenter cohort study found that early treatment with tocilizumab may reduce mortality among critically ill patients with COVID-19. Further research from randomized clinical trials is needed to confirm these findings.

JAMA INTERNAL MEDICINE (2021)

Article Biochemical Research Methods

Exploration of natural compounds with anti-SARS-CoV-2 activity via inhibition of SARS-CoV-2 Mpro

Shiv Bharadwaj et al.

Summary: By utilizing in silico and in vitro methods, natural compounds have been identified as promising candidates for inhibiting SARS-CoV-2 M-pro. These compounds show significant binding energy and molecular interactions with essential residues in the active site of the virus's main protease.

BRIEFINGS IN BIOINFORMATICS (2021)

Review Biochemistry & Molecular Biology

Structural insights into SARS-CoV-2 proteins

Rimanshee Arya et al.

Summary: The unprecedented scale of the ongoing COVID-19 pandemic has led to an intensive global scientific effort to understand various aspects of the disease in a short period. More than three hundred experimental structures of SARS-CoV-2 proteins have been determined recently, revealing the intricate workings of the viral machinery and their potential as drug targets.

JOURNAL OF MOLECULAR BIOLOGY (2021)

Article Biochemical Research Methods

ACE-2-Derived Biomimetic Peptides for the Inhibition of Spike Protein of SARS-CoV-2

Saroj Kumar Panda et al.

Summary: A peptide inhibitor with stronger interaction with the spike protein of SARS-CoV-2 has been discovered, potentially aiding in containing the virus. Peptides generated by mutating non-interacting residues of hACE-2 show higher efficacy in interaction with the spike protein.

JOURNAL OF PROTEOME RESEARCH (2021)

Article Microbiology

Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies

Allison J. Greaney et al.

Summary: The evolution of SARS-CoV-2 may impact the recognition of the virus by human antibody-mediated immunity, with mutations affecting antibody binding varying significantly among individuals and within the same individual over time. Despite this variability, mutations that greatly reduce antibody binding usually occur at specific sites in the RBD, with E484 being the most crucial. These findings can inform surveillance efforts for SARS-CoV-2 evolution in the future.

CELL HOST & MICROBE (2021)

Article Biochemistry & Molecular Biology

SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma

Constantinos Kurt Wibmer et al.

Summary: The SARS-CoV-2 virus in the B.1.351 variant discovered in South Africa can evade neutralization by most antibodies when expressed, but does not affect binding by convalescent plasma. This suggests the potential for reinfection with antigenically distinct variants and predicts reduced efficacy of spike-based vaccines.

NATURE MEDICINE (2021)

Article Biology

SARS-CoV-2 shifting transmission dynamics and hidden reservoirs potentially limit efficacy of public health interventions in Italy

Marta Giovanetti et al.

Summary: The study on SARS-CoV-2 transmission dynamics in Italy found that multiple lineages co-circulated, lockdown measures reduced infections but sporadic clusters continued to spread during summer.

COMMUNICATIONS BIOLOGY (2021)

Article Chemistry, Physical

OPLS4: Improving Force Field Accuracy on Challenging Regimes of Chemical Space

Chao Lu et al.

Summary: The development and validation of the OPLS4 force field, which builds upon previous work with OPLS3e, improved model accuracy on challenging regimes of drug-like chemical space. A novel parametrization strategy for charged species was introduced, leading to improved accuracy on benchmarks assessing small-molecule solvation and protein-ligand binding.

JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2021)

Article Multidisciplinary Sciences

SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma

Emanuele Andreano et al.

Summary: Research suggests that SARS-CoV-2 has the potential to generate variants resistant to neutralizing antibodies, and computational modeling predicts that these variants may prevent binding of neutralizing antibodies. Therefore, the development of vaccines and antibodies capable of controlling emerging variants is crucial.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Pharmacology & Pharmacy

A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor

Sajjan Rajpoot et al.

Summary: The study developed a 13-amino acid peptide inhibitor against the RBD of the SARS-CoV-2 spike protein using in silico methods. The inhibitor showed high affinity binding to the RBD and was able to significantly block the spike protein in vitro, indicating its potential as a therapeutic agent for COVID-19.

DRUGS IN R&D (2021)

Review Biochemistry & Molecular Biology

SARS-CoV-2: from its discovery to genome structure, transcription, and replication

Ayslan Castro Brant et al.

Summary: SARS-CoV-2 is a highly contagious respiratory virus causing adult atypical pneumonia COVID-19 with severe acute respiratory syndrome (SARS). This virus enters susceptible cells and directly translates polyproteins to initiate viral genome replication and transcription.

CELL AND BIOSCIENCE (2021)

Article Biology

Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics

Michael Barton et al.

Summary: The study analyzed the effects of mutations in the Spike protein of SARS-CoV-2 on its interaction with ACE2, finding that most mutations increased affinity with ACE2. Two ACE2 mutations were also found to enhance binding with the Spike protein.

ELIFE (2021)

Article Biochemistry & Molecular Biology

Structural Biology in the Clouds: The WeNMR-EOSC Ecosystem

Rodrigo Honorato et al.

Summary: Structural biology focuses on studying the structural and dynamic properties of biological macromolecules at atomic level, which is crucial for understanding cellular processes and has applications in health and food sciences. The WeNMR project has provided web-based services and high throughput computing infrastructure to over 23,000 users worldwide for 10 years, facilitating complex workflows in structural biology research.

FRONTIERS IN MOLECULAR BIOSCIENCES (2021)

Review Microbiology

The Emerging Concern and Interest SARS-CoV-2 Variants

Edyta Janik et al.

Summary: Since the discovery of the SARS-CoV-2 responsible for COVID-19 in December 2019, the virus has continually mutated, with three variants of concern and four variants of interest being distinguished in recent months and requiring close monitoring.

PATHOGENS (2021)

Article Biochemistry & Molecular Biology

SARS-COV-2 Mpro conformational changes induced by covalently bound ligands

Glaucio Monteiro Ferreira et al.

Summary: This study systematically simulated the interaction between SARS-CoV-2's M-pro and ligands, revealing that the M-pro dimer exhibited a more stable conformation with increased interaction frequencies with specific residues, which may significantly impact the inhibitory activity of the ligands.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Article Medicine, General & Internal

A Novel Coronavirus from Patients with Pneumonia in China, 2019

Na Zhu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Chemistry, Multidisciplinary

Computational Design of ACE2-Based Peptide Inhibitors of SARS-CoV-2

Yanxiao Han et al.

ACS NANO (2020)

Article Biochemistry & Molecular Biology

Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2

Qihui Wang et al.

Article Multidisciplinary Sciences

Cell entry mechanisms of SARS-CoV-2

Jian Shang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Review Medicine, General & Internal

A Systematic Review of COVID-19 Epidemiology Based on Current Evidence

Minah Park et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Article Multidisciplinary Sciences

Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors

Zhenming Jin et al.

NATURE (2020)

Article Biochemistry & Molecular Biology

Temporal dynamics in viral shedding and transmissibility of COVID-19

Xi He et al.

NATURE MEDICINE (2020)

Review Biochemistry & Molecular Biology

SARS-CoV-2 Entry Inhibitors: Small Molecules and Peptides Targeting Virus or Host Cells

Rolando Cannalire et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Chemistry, Medicinal

SARS-CoV-2 Main Protease: A Molecular Dynamics Study

Dimas Suarez et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)

Review Biochemistry & Molecular Biology

Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach

Ahmad Abu Turab Naqvi et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)

Article Chemistry, Physical

Antiviral Peptides as Promising Therapeutics against SARS-CoV-2

Surid Mohammad Chowdhury et al.

JOURNAL OF PHYSICAL CHEMISTRY B (2020)

Article Multidisciplinary Sciences

In-silico design of a potential inhibitor of SARS-CoV-2 S protein

Grijesh Jaiswal et al.

PLOS ONE (2020)

Article Multidisciplinary Sciences

De novo design of picomolar SARS-CoV-2 miniprotein inhibitors

Longxing Cao et al.

SCIENCE (2020)

Article Chemistry, Physical

Computational Design of 25-mer Peptide Binders of SARS-CoV-2

Thassanai Sitthiyotha et al.

JOURNAL OF PHYSICAL CHEMISTRY B (2020)

Article Genetics & Heredity

Genomic characterization of a novel SARS-CoV-2

Rozhgar A. Khailany et al.

GENE REPORTS (2020)

Article Chemistry, Medicinal

The Current State of Peptide Drug Discovery: Back to the Future?

Antoine Henninot et al.

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Review Biochemistry & Molecular Biology

RNA-virus proteases counteracting host innate immunity

Jian Lei et al.

FEBS LETTERS (2017)

Article Multidisciplinary Sciences

Structural insights into conformational stability of both wild-type and mutant EZH2 receptor

Imlimaong Aier et al.

SCIENTIFIC REPORTS (2016)

Article Chemistry, Medicinal

Peptide therapeutics: Targeting the undruggable space

Natia Tsomaia

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)

Article Biochemistry & Molecular Biology

NCBI Viral Genomes Resource

J. Rodney Brister et al.

NUCLEIC ACIDS RESEARCH (2015)

Article Biochemistry & Molecular Biology

PEP-FOLD: an updated de novo structure prediction server for both linear and disulfide bonded cyclic peptides

Pierre Thevenet et al.

NUCLEIC ACIDS RESEARCH (2012)

Article Biochemistry & Molecular Biology

Structural, Dynamic, and Chemical Characterization of a Novel S-Glycosylated Bacteriocin

Hariprasad Venugopal et al.

BIOCHEMISTRY (2011)

Article Chemistry, Medicinal

LigPlot+: Multiple Ligand-Protein Interaction Diagrams for Drug Discovery

Roman A. Laskowski et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)

Article Biochemistry & Molecular Biology

Three-dimensional structure of the two peptides that constitute the two-peptide bacteriocin lactococcin G

Per Rogne et al.

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2008)

Article Biochemistry & Molecular Biology

Structure and mechanism of action of the antimicrobial peptide piscidin

Sylvie Campagna et al.

BIOCHEMISTRY (2007)

Article Biochemistry & Molecular Biology

A hierarchical approach to all-atom protein loop prediction

MP Jacobson et al.

PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2004)

Article Chemistry, Multidisciplinary

UCSF chimera - A visualization system for exploratory research and analysis

EF Pettersen et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)

Article Biochemistry & Molecular Biology

SWISS-MODEL: an automated protein homology-modeling server

T Schwede et al.

NUCLEIC ACIDS RESEARCH (2003)

Article Chemistry, Multidisciplinary

HADDOCK: A protein-protein docking approach based on biochemical or biophysical information

C Dominguez et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)

Article Biochemistry & Molecular Biology

MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform

K Katoh et al.

NUCLEIC ACIDS RESEARCH (2002)

Article Biochemistry & Molecular Biology

On the role of the crystal environment in determining protein side-chain conformations

MP Jacobson et al.

JOURNAL OF MOLECULAR BIOLOGY (2002)